Searchable abstracts of presentations at key conferences in endocrinology

ea0030s20 | ENDOCRINE NURSES DAY | BSPED2012

Congenital hyperinsulinism the American experience

Rigby Lindsey

This presentation will focus on congenital hyperinsulinism (CHI) management within the Children’ Hospital of Philadelphia (CHOP), USA. This is following the inaugural endocrine nurses’ award presentation in 2010. The award was presented to allow travel to Philadelphia. Reports following a two day medical conference on CHI and a two day parent’s conference on CHI, as well as reports on two days working alongside the CHOP medical, nursing and research team will al...

ea0021p269 | Pituitary | SFEBES2009

When should an MRI pituitary scan be performed in hypogonadal men with low or low normal LH?

Rigby Emma , Jones Hugh

Background: There is no published guidance on when to request a pituitary MRI in hypogonadal men. The presence of low or low normal gonadotrophins is common in men with symptomatic testosterone deficiency and metabolic syndrome and/or type 2 diabetes. Our practise is to perform pituitary MRI scans in men with isolated hypogonadotrophic hypogonadism who have LH< 4 Iu/l.Method: One hundred and eighty-one patients that had a pituitary MRI scan between J...

ea0039ep81 | Miscellaneous/other | BSPED2015

Pilot study on the utility and acceptability of video animation as a delivery method for educational materials for families and carers of patients with congenital hyperinsulinism in infancy

Rodgers Elizabeth , Rigby Lindsey , Dunne Mark , Banerjee Indraneel , Cosgrove Karen

Introduction: To prevent neurological damage caused by congenital hyperinsulinism (CHI), hypoglycaemia must be avoided and treated promptly. Education of parents, carers and families of patients with CHI (PCFs) about the causes and consequences of CHI may help to reduce severity of hypoglycaemia due to earlier correction of blood glucose levels. We aimed to determine whether video animations could be used to improve understanding of CHI among PCFs, and the acceptability of thi...

ea0012p68 | Neuroendocrinology and behaviour | SFE2006

High cocoa polyphenol rich chocolate improves the symptoms of chronic fatigue

Sathyapalan T , Campion P , Beckett S , Rigby AS , Atkin SL

BackgroundChronic fatigue syndrome (CFS) is a debilitating condition with high morbidity and associated reduced quality of life. There are data suggesting neuro-endocrine axis involvement in CFS including disturbance in hypothalamic-pituitary-adrenal axis, growth hormone axis, opioidergic system and interactions with 5-Hydroxy Tryptamine (5-HT) system. Studies with selective 5-HT-releasing agents, using prolactin or cortisol responses to stimulation, fou...

ea0050p323 | Obesity and Metabolism | SFEBES2017

A randomised controlled trial of vitamin D treatment on markers of liver fibrosis in obese women with Polycystic Ovary Syndrome

Javed Zeeshan , Kilpatrick Eric , Mann Vincent , Corless Lynsey , Abouda George , Rigby Alan , Atkin Stephen , Sathyapalan Thozhukat

Context: Polycystic ovary syndrome (PCOS) has been linked to non-alcoholic fatty liver disease (NAFLD) that carries an increased risk of liver cirrhosis. The Enhanced Liver Fibrosis (ELF) score comprises serum hyaluronic acid (HA), procollagen III N-terminal peptide (PIIINP) and tissue inhibitor of metalloproteinase-1 (TIMP1) that correlate with hepatic fibrosis staging.Objective: To determine the effect of vitamin D suppleme...

ea0050p323 | Obesity and Metabolism | SFEBES2017

A randomised controlled trial of vitamin D treatment on markers of liver fibrosis in obese women with Polycystic Ovary Syndrome

Javed Zeeshan , Kilpatrick Eric , Mann Vincent , Corless Lynsey , Abouda George , Rigby Alan , Atkin Stephen , Sathyapalan Thozhukat

Context: Polycystic ovary syndrome (PCOS) has been linked to non-alcoholic fatty liver disease (NAFLD) that carries an increased risk of liver cirrhosis. The Enhanced Liver Fibrosis (ELF) score comprises serum hyaluronic acid (HA), procollagen III N-terminal peptide (PIIINP) and tissue inhibitor of metalloproteinase-1 (TIMP1) that correlate with hepatic fibrosis staging.Objective: To determine the effect of vitamin D suppleme...

ea0059p156 | Obesity &amp; metabolism | SFEBES2018

Randomised trial of empagliflozin versus metformin in polycystic ovary syndrome

Javed Zeeshan , Papageorgiou Maria , Kilpatrick Eric , Abbas Jehangir , Khan Amer , Rigby Alan , Atkin Stephen , Sathyapalan Thozhukat

Background: Empagliflozin is a sodium-glucose-cotransporter-2 that improves cardiovascular risk and weight loss in patients with type 2 diabetes. Polycystic ovary syndrome (PCOS) is associated with obesity and increased cardiovascular risk; therefore, empagliflozin may be of benefit in PCOS.Methods: A randomised, open-label study in 40 overweight and obese women with PCOS treated with either empagliflozin 25 mg or metformin 1500mg daily for 12 weeks....

ea0038p246 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

The effect of soy protein with and without isoflavones in men with type 2 diabetes mellitus and subclinical hypogonadism: a randomised double-blind parallel study

Sathyapalan Thozhukat , Thatcher Natalie J , Rigby Alan S , Kilpatrick Eric S , Atkin Stephen L

Isoflavones are a subgroup of phytoestrogens and have a chemical structure similar to oestrogen, leading to concerns regarding possible adverse effects of isoflavones in men. Testosterone levels in men with type 2 diabetes mellitus (T2DM) are lower.Materials and methods: A randomised double-blind, parallel study was undertaken with 200 men with T2DM, of median age of 50 years (25th/75th centiles; 50, 55) years with a total testosterone level ≤12 nm...

ea0038p439 | Thyroid | SFEBES2015

Soy protein with isoflavones impairs thyroid function

Sathyapalan Thozhukat , Aye Mo , Thatcher Natalie J , Rigby Alan S , Kilpatrick Eric S , Atkin Stephen L

: In patients with subclinical hypothyroidism, soy protein and isoflavone combination has been shown to increase the risk of developing overt hypothyroidism; however, it is unclear if soy affects thyroid function in those without existing thyroid compromise.Materials and methods: Two double blind randomised trials were undertaken in which thyroid function was performed routinely at the beginning and end as a secondary end point. In both trials soy protei...

ea0038p444 | Thyroid | SFEBES2015

The effect of isoflavone-free soy protein supplementation on thyroid status and cardiovascular risk markers in patients with subclinical hypothyroidism: a randomised double blind crossover study

Sathyapalan Thozhukat , Javed Zeeshan , Thatcher Natalie J , Rigby Alan S , Kilpatrick Eric S , Atkin Stephen L

Context: Soy phytoestrogens are suggested to have an adverse effect on thyroid function but the contribution to this by soy protein alone when free from isoflavones is unknown.Objective: The primary aim was to determine the effect of isoflavone free soy protein supplementation on thyroid function, with a secondary aim of assessing the effects on cardiovascular risk indices in patients with subclinical hypothyroidism.Design and sett...